
Hermab 150mg Injection
Marketer
RPG Life Sciences Ltd
Salt Composition
Trastuzumab (150mg)
Overview Hermab 150mg Injection
Trastuzumab 150mg injection treats breast and gastric cancers by targeting and destroying HER2-positive cancer cells. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your individual needs and may vary. Strict adherence to your doctor's prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be immediately apparent, requiring weeks or months; discontinuation should only occur under medical supervision. Common side effects include nausea, headache, skin rash, sleep disturbances, and increased infection risk. This medication can suppress blood cell production, potentially increasing infection vulnerability, necessitating regular blood tests to monitor blood counts, heart function, liver health, and uric acid levels. Report any shortness of breath, cough, chills, or limb swelling to your doctor immediately. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout the treatment period.
Uses of Hermab 150mg Injection
Cancers affecting the breast and stomach.
Major Benefits of Hermab 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Hermab 150mg Injection:
- Anemia (low number of red blood cells)
- Chills
- Common cold
- Cough
- Decreased blood cells (red cells, white cells, and platelets)
- Diarrhea
- Fatigue
- Fever
- Headache
- Heart failure
- Infection
- Insomnia (difficulty in sleeping)
- Mucosal inflammation
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Taste change
- Upper respiratory tract infection
- Weight loss
How to use Hermab 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Hermab 150mg Injection works:
Hermab 150mg Injection, a genetically engineered IgG1 monoclonal antibody, targets HER2 receptors—proteins driving excessive growth in breast and gastric cancers. By blocking HER2 activity, it eliminates cancer cells and disrupts multiple downstream signaling pathways implicated in cancer development.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Hermab 150mg Injection and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Hermab 150mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Administration of Hermab 150mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Hermab 150mg Injection's effect on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Hermab 150mg Injection appears safe for use in individuals with kidney impairment. Preliminary findings indicate dose modification may be unnecessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Hermab 150mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Hermab 150mg Injection :
Omit a Hermab 150mg Injection dose? Seek your physician's advice.
Facts to Know About Hermab 150mg Injection
Label | Value |
---|---|
Chemical Type | Monoclonal antibody |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Action Class | Monoclonal Antibody HER2/neu (ErbB2) Inhibitor |